Press

Dec11th2018

Canary announces Partnership with Dutch breeder Serious Seeds

Canary Rx Inc. (“Canary”), is thrilled to announce our partnership with Serious Seeds B.V. (“Serious Seeds”). Serious Seeds is a world renowned and...

Read More

Oct30th2018

Canary Rx Inc. Provides an Update on Construction at 44,000 Square Foot Norfolk County Cannabis Cultivation Facility

Canary Rx Inc. Provides an Update on Construction at 44,000 Square Foot Norfolk County Cannabis Cultivation Facility Canary Rx Inc. (“Canary”) (the “Company”)...

Read More

Oct24th2018

Target Group Inc. Announces Upgrade to the OTCQB Venture Market

Target Group Inc. (“Target” or the “Company”) (OTC: CBDY) announced today its Common shares have been upgraded to a listing on the OTCQB...

Read More

Aug8th2018

Target Group Inc. Announces the Completion of Acquisition of Visava Inc.

Effective August 2, 2018, Target Group Inc. (CBDY) completed the acquisition of all of the issued and outstanding common stock of Visava Inc. (“Visava”)....

Read More

Jul7th2018

Canary Receives ‘Confirmation of Readiness’ from Health Canada

Late stage ACMPR Applicant, Canary, receives ‘Letter of Readiness’ from Health Canada Canary Rx Inc. (“Canary”) is pleased to announce that it has...

Read More

Jun13th2018

Ample Organics, Seed to Sale Experts

Canary’s Intuitive, Systematic, Record Keeping Platform One of the key requirements of the Access to Cannabis for Medical Purposes Regulations (ACMPR) is that...

Read More

Mar26th2018

Canary Progresses to Active Review

Health Canada Notifies Canary of Active Review Status Canary Rx Inc. (“Canary”) is pleased to announce that its application to become a licensed...

Read More

Dec16th2017

Canary has Officially Rebranded

Canary is Dropping the RX, and Adopting a Sleek New Look to Prepare for Licensing Canary is delighted to officially unveil our company-wide...

Read More